Literature DB >> 35602978

Membranous Ventricular Septal Aneurysm Leading to Embolic Stroke.

Timothy Colangelo1, Priscilla Peters1, Marie Sadler1, Lucy M Safi2.   

Abstract

Entities:  

Keywords:  Embolism; Ischemic stroke; Membranous ventricular septal aneurysm; Ultrasound enhancing agent

Year:  2022        PMID: 35602978      PMCID: PMC9120855          DOI: 10.1016/j.case.2022.01.010

Source DB:  PubMed          Journal:  CASE (Phila)        ISSN: 2468-6441


× No keyword cloud information.

Introduction

Echocardiography is often ordered to assess for a cardiac source of embolism after an acute neurologic event. Common cardiac culprits for thromboembolism include cardiac masses, thrombi, vegetations, mobile atheromas, or a cryptogenic embolism in the setting of patent foramen ovale. Membranous ventricular septum aneurysm (MVSA) is a rare abnormality that may be congenital or acquired. Blood stasis within these aneurysms increases the risk of thrombosis formation.

Case Presentation

A 51-year-old woman with a medical history of diabetes, hypertension, and cognitive impairment presented with aphasia and right-sided hemiplegia. She had no history of congenital heart disease. Her vital signs were within normal limits, and the cardiac examination was unremarkable. Pertinent medication included a daily oral contraceptive. An emergent computed tomography angiogram of the head and neck revealed an acute left middle cerebral infarct, and subsequent cerebral angiogram showed a nonocclusive thrombus within two middle cerebral artery branches consistent with embolic etiology. A transthoracic echocardiogram (TTE) was ordered to assess for a cardiac source of emboli. The TTE showed a thin-walled outpouching of the basal segment of the MVSA protruding into the right ventricular outflow tract (RVOT), consistent with a MVSA (Figure 1, Figure 2, Figure 3, Videos 1-5). Flow was seen into the MVSA by color Doppler (Video 1) with no evidence of a ventricular septal defect (VSD). There was no evidence of RVOT obstruction by pulsed-wave Doppler (Figure 2). Administration of an ultrasound-enhancing agent (UEA) revealed a discrete echo density within the aneurysm suggestive of thrombus (Figure 3B, Video 4). For further assessment of an echodensity, an electrocardiogram-gated cardiac computed tomography (CCT) was ordered that confirmed the MVSA and a 0.8 × 1.2 cm thrombus within the aneurysmal space (Figure 4). No thrombus was seen in the left atrial appendage.
Figure 1

Two-dimensional TTE, modified parasternal long-axis orientation in late-diastolic phase demonstrates the large MVSA (arrow). AV, Aortic valve; LA, left atrium; LV, left ventricle; RV, right ventricle.

Figure 2

Two-dimensional basal parasternal short-axis view, pulsed-wave Doppler of the RVOT.

Figure 3

Two-dimensional TTE, apical five-chamber view, diastolic phase without (A) and with (B) an UEA demonstrates the large MVSA (∗) bulging into the RV. A filling defect is seen inside the MVSA (arrow) consistent with a suspected thrombus (B). LA, Left atrium; LV, left ventricle; RV, right ventricle. The arrow indicates the thrombus.

Figure 4

Contrast-enhanced CCT scan, multiplanar reconstruction, coronal display (A), and maximal intensity projection with increased slice thickness, oblique sagittal short-axis display (B). The filling defect (thrombus) is well visualized (arrows) and can be measured at 0.8 × 1.2 cm. Ao, Ascending aorta; AV, aortic valve; LV, left ventricle; PV, pulmonic valve. The arrow indicates the thrombus.

Two-dimensional TTE, modified parasternal long-axis orientation in late-diastolic phase demonstrates the large MVSA (arrow). AV, Aortic valve; LA, left atrium; LV, left ventricle; RV, right ventricle. Two-dimensional basal parasternal short-axis view, pulsed-wave Doppler of the RVOT. Two-dimensional TTE, apical five-chamber view, diastolic phase without (A) and with (B) an UEA demonstrates the large MVSA (∗) bulging into the RV. A filling defect is seen inside the MVSA (arrow) consistent with a suspected thrombus (B). LA, Left atrium; LV, left ventricle; RV, right ventricle. The arrow indicates the thrombus. Contrast-enhanced CCT scan, multiplanar reconstruction, coronal display (A), and maximal intensity projection with increased slice thickness, oblique sagittal short-axis display (B). The filling defect (thrombus) is well visualized (arrows) and can be measured at 0.8 × 1.2 cm. Ao, Ascending aorta; AV, aortic valve; LV, left ventricle; PV, pulmonic valve. The arrow indicates the thrombus. The patient was seen by cardiothoracic surgery, and medical management was recommended. The patient’s oral contraceptive was discontinued, and oral anticoagulation was initiated with close outpatient cardiology follow-up.

Discussion

The membranous septum is located in the midportion of the ventricular septum just inferior to the aortic valve annulus. Aneurysm formation of this segment is an uncommon occurrence and may be related to a spontaneous partial or complete closure of a congenital VSD by approximation of the septal leaflet of the tricuspid valve across the defect. These may also be idiopathic or develop after previous infection or trauma. Transthoracic echocardiogram is the first-line imaging modality; however, supplementary CCT may be helpful when the anatomy remains unclear. Cardiac computed tomography provides improved spatial resolution and is devoid of acoustic shadowing. Given the proximity of the membranous septum to the aortic valve, a sinus of Valsalva aneurysm (SoVA) must be included in the differential diagnosis. Sinus of Valsalva aneurysm is associated with a more aggressive course and a higher likelihood of rupture. Cardiac computed tomography can help distinguish a SoVA from an MVSA as it provides sharper delineation of the cardiac structures. A SoVA shows saccular dilatation of the aortic sinus, compared with an MVSA, which shows an outpouching of the ventricular septum below the aortic valve., Membranous ventricular septum aneurysms are often clinically silent; however, if present they can be associated with significant complications including thromboembolism, aortic valve leaflet prolapse, tricuspid regurgitation, RVOT obstruction, conduction abnormalities, or acute left-to-right shunting secondary to aneurysmal rupture. The aneurysmal sac allows for stasis of blood flow and the potential for thrombus formation. Distal embolization due to thrombus formation within the aneurysmal space is rare, with few documented case reports.4, 5, 6 Due to the anatomical location of the membranous septum, interference with the aortic valve can lead to aortic valve leaflet prolapse and subsequent aortic insufficiency. The aneurysm may impinge on the tricuspid valve apparatus, leading to tricuspid regurgitation. If large, the MVSA can protrude into the RVOT and cause obstruction. Despite the large size of the aneurysm in our case, there was no RVOT obstruction or significant aortic or tricuspid regurgitation (Figure 2, Video 6). Valvular calcification, echocardiographic artifacts, slow flow into the chambers, and poor imaging windows may add technical challenges in evaluating an aneurysm for thrombus. Opacifying aneurysm chambers with an UEA is helpful to delineate chamber borders and evaluate for filling defects that are seen with masses. Ultrasound-enhancing agent hyperenhancement of visualized masses suggests vascularity and thus can help distinguish neoplasm from thrombus. It is important to note that sweeping through a large aneurysm or using biplane imaging is helpful and often necessary to fully assess the entire aneurysm for the presence or absence of a filling defect. A small thrombus within the aneurysm may be missed if only a single location is imaged. Cardiovascular magnetic resonance imaging provides a higher sensitivity for identifying left ventricular thrombus compared with TTE. Cardiovascular magnetic resonance imaging offers tissue characterization that is highly effective in differentiating thrombus from neoplasm. Thrombi, as opposed to neoplasms, lack a vascular supply and, using the late gadolinium enhancement technique, do not enhance. There are no established management guidelines for the treatment of an MVSA in the absence of significant related complications or concomitant cardiac surgery. If a thrombus is identified within the aneurysm, initial management is focused on treatment of the thrombus with anticoagulation and the consideration of surgical intervention. Percutaneous interventions with coiling and/or placement of occluder devices to exclude left ventricular aneurysms in other locations of the left ventricle have been reported. The location of this patient’s aneurysm would make percutaneous closure challenging due to proximity to the aortic valve and the wide base of the aneurysm.

Conclusion

Membranous ventricular septum aneurysms are rare congenital anomalies that may lead to blood stasis and thrombus formation. Color Doppler echocardiography is useful in confirming or excluding the presence of concomitant VSD. When evaluating a patient for a cardiac source of embolus, thorough evaluation of ventricular aneurysms using color Doppler and an UEA is recommended to exclude or confirm the presence of a thrombus. Supplemental imaging with CCT and cardiovascular magnetic resonance imaging may also be useful in certain cases.
  11 in total

1.  Ventricular septal aneurysms in adults: findings of cardiac CT images and correlation with clinical features.

Authors:  Maria Choi; Jung Im Jung; Bae Young Lee; Hyo Rim Kim
Journal:  Acta Radiol       Date:  2011-04-06       Impact factor: 1.990

2.  2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Karen K Stout; Curt J Daniels; Jamil A Aboulhosn; Biykem Bozkurt; Craig S Broberg; Jack M Colman; Stephen R Crumb; Joseph A Dearani; Stephanie Fuller; Michelle Gurvitz; Paul Khairy; Michael J Landzberg; Arwa Saidi; Anne Marie Valente; George F Van Hare
Journal:  J Am Coll Cardiol       Date:  2018-08-16       Impact factor: 24.094

3.  Aneurysm of the membranous ventricular septum. A mechanism for spontaneous closure of ventricular septal defect.

Authors:  K P Misra; F J Hildner; L S Cohen; O S Narula; P Samet
Journal:  N Engl J Med       Date:  1970-07-09       Impact factor: 91.245

4.  Membranous ventricular septum aneurysm, differentiated from sinus of valsalva aneurysm using cardiac CT.

Authors:  Ashvarya Mangla; Dinesh K Kalra
Journal:  J Cardiovasc Comput Tomogr       Date:  2017-08-15

5.  Percutaneous exclusion of left ventricular pseudoaneurysm.

Authors:  Marco B Ancona; Emanuele Visco; Barbara Bellini; Vittorio Romano; Ciro Vella; Luca Ferri; Filippo Russo; Alessandro Beneduce; Francesco Ancona; Davide Vignale; Antonio Esposito; Alaide Chieffo; Eustachio Agricola; Matteo Montorfano
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2021-11-01       Impact factor: 2.160

6.  Cerebral embolism from the thrombus in the atrioventricular septal aneurysm.

Authors:  J M Lin; J J Hwang; I S Chiu
Journal:  Cardiology       Date:  1995       Impact factor: 1.869

7.  Aneurysm of the interventricular membranous septum with thrombo-embolism--an indication for surgical repair?

Authors:  D Thomas; J Salloum; G Rancurel
Journal:  Eur Heart J       Date:  1993-12       Impact factor: 29.983

8.  Interventricular membranous septal aneurysm: CT and MR manifestations.

Authors:  Carolina Carcano; Jeffrey P Kanne; Jacobo Kirsch
Journal:  Insights Imaging       Date:  2015-12-21

9.  Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.

Authors:  Angel T Chan; Josef Fox; Rocio Perez Johnston; Jiwon Kim; Lillian R Brouwer; John Grizzard; Raymond J Kim; Mathew Matasar; Jinru Shia; Chaya S Moskowitz; Richard Steingart; Jonathan W Weinsaft
Journal:  J Am Heart Assoc       Date:  2019-05-21       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.